Agilent Technologies Inc. has launched new SureScan Dx microarray scanner that is CE marked for in vitro diagnostic use in Europe. The SureScan Dx microarray scanner is indicated for use in a clinical ...
(MENAFN- Ameliorate Digital Consultancy) The global Microarray Scanner market is projected to reach USD 5.52 billion by 2023, at a CAGR of 7.8%. The major factors driving the growth of this market are ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification ...
Pathology laboratories worldwide are under increasing pressure to improve diagnostic precision and operational efficiency while managing growing sample volumes and case complexity. As a result, labs ...
Definition: A microarray is a small, flat substrate carrying an ordered grid of microscopic probe features, each containing a known biological molecule, that is used to measure many molecular targets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results